MXDHF News and Press, Mdxhealth Sa From 09/06/18

Redwood City, CA-based Guardant Health ( GH ) has filed a prospectus for a $100M IPO. More news on: Guardant Health, TrovaGene, Inc., Roche Holding Ltd ADR, Healthcare stocks news, IPOs, Read more ...

The following slide deck was published by MDXHealth SA in conjunction with their 2018 Q2 earnings Read more ...

MDXHealth SA (MXDHF) Q2 2018 Results Earnings Conference Call August 30, 2018, 09:00 AM ET Executives Jan Groen - CEO Jean-Marc Roelandt - CFO Analysts Stephanie Put - Lenny Van Steenhuyzen - Michaël Vlemmix - KBC Securities Howard Halpern - Presentation ...

MDXHealth SA ( OTCPK:MXDHF ): 1H GAAP EPS of -$0.27. More news on: MDXHealth SA, Earnings news and commentary, Healthcare stocks news, , Read more ...

MDXHealth SA ( OTCPK:MXDHF ): Q1 net loss of $6.7M More news on: MDXHealth SA, Earnings news and commentary, Healthcare stocks news, , Read more ...

MDxHealth SA ( OTCPK:MXDHF ) announces that the European Association of Urology has included its SelectMDx prostate cancer liquid biopsy test in its 2018 treatment guidelines. More news on: MDXHealth SA, Healthcare stocks news, Read more ...

MDXHealth SA ( OTCPK:MXDHF ): FY EPS of -$0.25 Revenue of $40.5M (+35.1% Y/Y) Press Release More news on: MDXHealth SA, Earnings news and commentary, Healthcare stocks news, ,

MDxHealth SA ( OTCPK:MXDHF ) announces that it is developing a liquid biopsy test to help guide personalized treatment for castration-resistant prostate cancer (CRPC). The PCR-based blood test measures hypermethylation levels of two biomarkers (GSTP1 and APC) in plasma cell-free DNA. Mor...